American NGOs join cancer fight in Ethiopia, Uganda and Tanzania
(EBC; November 17, 2017) - Novartis, the American Society for Clinical Pathology (ASCP) and the American Cancer Society (ACS) announced Wednesday they will work together to devise a common approach to improve access to cancer treatment in Sub-Saharan Africa.
According to the announcement, ASCP will build healthcare capacity for immuno-histochemistry (IHC) analysis in two hospital laboratories in Ethiopia and Tanzania.
ACS will support training of healthcare professionals in Ethiopia, Tanzania and Uganda to ensure quality processes in the transportation of biopsy samples and in the administration of chemotherapy.
The plan is to implement these initiatives in the following hospitals in Ethiopia, Tanzania and Uganda:
In Ethiopia, Tikur Anbessa (Black Lion) Specialized Hospital in Addis Ababa is the only comprehensive cancer center in the country.
To address the lack of access to cancer services, the government has reactivated its immunohistochemistry program, and has launched an ambitious breast cancer treatment expansion program for twelve additional hospitals.
The model is expected to be an essential stepping stone toward Ethiopia's plan to open five new comprehensive cancer centers by 2020.